The major histocompatibility complex of the guinea-pig. II. Relationship between mixed leucocyte reactivity and serologically-defined phenotypes of the GPLA B locus and I region.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 61245)

Published in J Immunogenet on June 01, 1976

Authors

A F Geczy, A L de Weck

Articles by these authors

Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort. N Engl J Med (1999) 3.30

Evidence for a specific B27-associated cell surface marker on lymphocytes of patients with ankylosing spondylitis. Nature (1979) 2.79

Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. Bull World Health Organ (1968) 2.79

A factor(s) in Klebsiella culture filtrates specifically modifies an HLA-B27 associated cell-surface component. Nature (1980) 2.49

HLA-B27, Klebsiella and ankylosing spondylitis: biological and chemical studies. Immunol Rev (1983) 1.99

Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals. J Exp Med (1988) 1.79

Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1. J Virol (1999) 1.63

Studies on the induction of immunological tolerance by antigen in guinea-pigs already sensitized to dinitrochlorobenzene. Clin Exp Immunol (1971) 1.55

Lymphocyte transformation in contact sensitivity. Immunology (1970) 1.54

The immunogenicity of dinitrophenyl amino acids. J Exp Med (1969) 1.52

Interleukin 3-dependent mediator release in basophils triggered by C5a. J Exp Med (1989) 1.48

Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a. Proc Natl Acad Sci U S A (1990) 1.30

Superoxide-dependent nitroblue tetrazolium reduction and expression of cytochrome b-245 components by human tonsillar B lymphocytes and B cell lines. J Immunol (1989) 1.27

The induction of contact hypersensitivity to dinitrochlorobenzene (DNCB) in guinea-pigs by dinitrophenyl-amino acids. Int Arch Allergy Appl Immunol (1966) 1.26

HLA-B27, Klebsiella, and ankylosing spondylitis. Lancet (1979) 1.26

Immunochemical characterization of Klebsiella antigens which specifically modify an HLA-B27-associated cell-surface component. Hum Immunol (1982) 1.25

Lymphoproliferative immune function in the Sydney Blood Bank Cohort, infected with natural nef/long terminal repeat mutants, and in other long-term survivors of transfusion-acquired HIV-1 infection. AIDS (1997) 1.21

Antiserum to Klebsiella K43 BTS 1 specifically lyses lymphocytes of HLA-B27-positive patients with ankylosing spondylitis from a London population. Lancet (1985) 1.20

Sensitization, immunological tolerance and desensitization of guinea pigs to neoarsphenamine. IV. Desensitization to NEO. Int Arch Allergy Appl Immunol (1966) 1.19

Induction of delayed hypersensitivity by dinitrophenylated lymphocytes. Immunology (1970) 1.17

Lymphokine regulation of activated (G1) lymphocytes. II. Glucocorticoid and anti-Tac-induced inhibition of human T lymphocyte proliferation. J Immunol (1984) 1.16

Production and in vivo effect of antibodies against guinea pig lymphokines. Cell Immunol (1975) 1.11

Immunological tolerance in contact-hypersensitivity to dinitrochlorobenzene. Dose and time dependence. Possible cellular kinetics. Immunology (1971) 1.10

[Cheese washer's disease ("Kaesewascherkrankheit"), a special form of farmer's lung syndrome]. Schweiz Med Wochenschr (1969) 1.09

A new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol (2004) 1.07

The major histocompatibility complex of the guinea pig. I. Serologic and genetic studies. J Immunol (1975) 1.07

The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Clin Exp Allergy (2004) 1.04

The immunopathology of ankylosing spondylitis--a review. Semin Arthritis Rheum (1985) 1.04

Flow cytometric basophil activation test: a review. J Investig Allergol Clin Immunol (2002) 1.02

Persistence of HLA-B27 cross-reactive bacteria in bowel flora of patients with ankylosing spondylitis. Infect Immun (1984) 1.01

The guinea pig I region. II. Functional analysis. J Exp Med (1977) 1.01

Histocompatibility antigens and genetic control of the immune response in guinea pigs. III. Specific inhibition of antigen-induced lymphocyte proliferation by strain-specific anti-idiotypic antibodies. J Exp Med (1976) 1.01

Enteric bacteria and HLA-B27 associated cell surface modification in patients with seronegative spondarthritis. Br J Rheumatol (1983) 1.01

Cytotoxic T lymphocytes against disease-associated determinant(s) in ankylosing spondylitis. J Exp Med (1986) 0.99

Characterization of a factor(s) present in Klebsiella culture filtrates that specifically modifies an HLA-B27-associated cell-surface component. J Exp Med (1980) 0.99

[Chemical aspects of penicillin allergy. The direct penicilloylation of epsilon-amino groups by penicillin at pH 7.4]. Helv Chim Acta (1966) 0.99

Suppression of the benzylpenicilloyl- (BPO) specific IgE formation with isologous anti-idiotypic antibodies in BALB/c mice. J Immunol (1980) 0.98

Effect of storage of penicillin-G solutions on sensitisation to penicillin-G after intravenous administration. Lancet (1982) 0.98

The role of Klebsiella in the pathogenesis of ankylosing spondylitis. II Evidence for a specific B27-associated marker on the lymphocytes of patients with ankylosing spondylitis. J Clin Lab Immunol (1980) 0.98

Influence of FcgammaRIIA and MBL polymorphisms on severe acute respiratory syndrome. Tissue Antigens (2005) 0.98

Anti-amiodarone antibodies: detection and relationship to the development of side effects. Am J Med (1988) 0.97

Antibodies to guinea pig lymphokines. IV. Suppression of the mixed leukocyte culture reaction by anti-lymphokine globulin. J Immunol (1976) 0.97

Antibodies to guinea pig lymphokines. II. Suppression of delayed hypersensitivity reactions by a "second generation" goat antibody against guinea pig lymphokines. J Immunol (1976) 0.96

Hypothesis: the etiology of ankylosing spondylitis: does a plasmid trigger the disease in genetically susceptible individuals? Hum Immunol (1983) 0.96

Search for Klebsiella cell wall components cross-reactive with lymphocytes of B27+ AS+ individuals. Hum Immunol (1980) 0.96

Solubility enhancing haptens: preparation and some properties of conjugates with dinitrocarboxyphenyl (DNCP) groups. Immunochemistry (1974) 0.95

Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function. J Immunol (1984) 0.95

Neutropenia after penicillins: toxic or immune-mediated? Klin Wochenschr (1981) 0.95

The role of penicilloylated protein impurities, penicillin polymers and dimers in penicillin allergy. Int Arch Allergy Appl Immunol (1968) 0.95

In vitro stimulation of bovine leucocytes by phytohaemagglutinin and other mitogens. Res Vet Sci (1974) 0.93

A survey of isolates of Klebsiella pneumoniae which cross-react with HLA-B27-associated cell-surface structure on the lymphocytes of patients with ankylosing spondylitis. J Rheumatol (1982) 0.92

Flow-cytometric analysis of human basophil degranulation. II. Degranulation induced by anti-IgE, anti-IgG4 and the calcium ionophore A23187. Clin Allergy (1981) 0.92

Genetic control of sensitization to structurally unrelated antigens and its relationship to histocompatibility antigens in guinea-pigs. Immunology (1975) 0.92

A factor shed by lymphoblastoid cell lines of HLA-B27 positive patients with ankylosing spondylitis, specifically modifies the cells of HLA-B27 positive normal individuals. Clin Exp Immunol (1983) 0.92

A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants. Clin Exp Immunol (1995) 0.92

Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5. J Immunol (1991) 0.92

Significance of non-pathogenic cross reactive bowel flora in patients with ankylosing spondylitis. Ann Rheum Dis (1986) 0.91

Effect of long-term infection with nef-defective attenuated HIV type 1 on CD4+ and CD8+ T lymphocytes: increased CD45RO+CD4+ T lymphocytes and limited activation of CD8+ T lymphocytes. AIDS Res Hum Retroviruses (1999) 0.91

The guinea-pig I-region. III. Distribution of Ia antigens in inbred and partially inbred strains. J Immunogenet (1980) 0.91

Monovalent elicitation of passive cutaneous anaphylaxis by N1-DNCP-N6-BPO-diaminohexane. Mol Immunol (1979) 0.91

Human lymphocyte proliferation. II. Formation of activated (G1) cells. Eur J Immunol (1982) 0.91

Histocompatibility antigens and genetic control of the immune response in guinea pigs. I. Specific inhibition of antigen-induced lymphocyte stimulation by alloantisera. Eur J Immunol (1974) 0.91

Is a Klebsiella plasmid involved in the aetiology of Ankylosing Spondylitis in HLA-B27-positive individuals? Mol Immunol (1983) 0.89

Induction of granulocyte chemiluminescence by a mediator derived from human monocytes. Lymphokine Res (1986) 0.88

Studies on the direct neutral penicilloylation of functional groups occurring on proteins. Biochim Biophys Acta (1968) 0.88

The enigma of the Klebsiella connection and ankylosing spondylitis: a commentary. Hum Immunol (1984) 0.88

[Antigenicity of hapten-polysaccharide conjugates]. Eur J Immunol (1971) 0.88

Interleukin 8-inhibitor and inducer of histamine and leukotriene release in human basophils. Biochem Biophys Res Commun (1991) 0.87

HLA-B27 associated cross-reactive marker on the cells of New Zealand patients with ankylosing spondylitis. Ann Rheum Dis (1986) 0.87

Sensitization, immunological tolerance and desensitization of guinea pigs to neoarsphenamine. 3. Immunological tolerance to NEO. Int Arch Allergy Appl Immunol (1966) 0.87

Regulation of the IgE antibody response by idiotype-anti-idiotype network. Prog Allergy (1982) 0.87

The reaction of benzylpenicillin with carbohydrates at neutral pH with a note on the immunogenicity of hapten polysaccharide conjugates. Immunochemistry (1967) 0.87

Pharmacological and immunological aspects of histamine release from horse leucocytes. Int Arch Allergy Appl Immunol (1980) 0.87

Identification of the site of uptake of the E. coli heat-labile enterotoxin, LTB. Scand J Immunol (1994) 0.86

Aspects of formation of the D-penicillamine-antigenic determinant from penicilloyl compounds. Helv Chim Acta (1973) 0.86

Cytofluorometric analysis of macrophages activated in vivo or in vitro. Eur J Immunol (1978) 0.86

[Immunological mechanisms of allergy reactions to antibiotics: topical aspects of penicillin therapy (author's transl)]. Munch Med Wochenschr (1973) 0.86

The guinea pig I region. I. A structural and genetic analysis. J Exp Med (1977) 0.86

Cross-reactivity between environmental agents and HLA-B2. Lancet (1980) 0.86

Induction of specific anti-guinea pig T cell sera in rabbits. J Immunol Methods (1976) 0.85

Natural anti-IgE auto-antibodies interfere with diagnostic IgE determination. Clin Exp Allergy (1990) 0.85

Effect of cyclosporin A on the early activation of human T helper lymphocytes: inhibition of RNA-synthesis and modification of the expression of activation antigens. Immunobiology (1985) 0.85

Sensitization, immunological tolerance and desensitization of guinea pigs to neoarsphenamine. I. Sensitization to NEO. Overall results and experiments on the skin testing technique. Int Arch Allergy Appl Immunol (1966) 0.85

IgG anti-IgE autoantibodies in immunoregulation. Int Arch Allergy Appl Immunol (1991) 0.85

Histocompatibility antigens and genetic control of the immune response in guinea pigs. II. Specific inhibition of antigen-induced lymphocyte proliferation by anti-receptor alloantisera. Eur J Immunol (1975) 0.85

The distribution of a specific HLA-B27-associated cell surface component on the tissues of patients with ankylosing spondylitis. Clin Exp Immunol (1981) 0.85

Lymphokines. I. Use of insoluble concanavalin A for the production of migration inhibitory factor in guinea pig lymphocyte cultures. Int Arch Allergy Appl Immunol (1975) 0.85

Membrane receptors for the IgG4 subclass on human basophils and mast cells. Clin Rev Allergy (1983) 0.84

Genetic control of allogeneic interactions in the guinea pig. I. Evidence from mixed leukocyte culture and normal lymphocyte transfer reactions. Eur J Immunol (1978) 0.84

Molecular models for induction of the immune response and their relationship to the genetic control of histocompatibility antigens. Transplant Rev (1972) 0.83

Genetic control of allogeneic interactions in the guinea-pig. II. Evidence for alloantigen-specific suppressor cells in the guinea-pig mixed leukocyte culture. J Immunogenet (1981) 0.83

Receptor-operated activation of polymorphonuclear leukocytes: different effects of NAP-1/IL-8 and fMet-Leu-Phe or C5a. Biochem Biophys Res Commun (1991) 0.83

HLA-B27: speculations on the nature of its involvement in ankylosing spondylitis. Prog Allergy (1985) 0.83

Guinea pig histocompatibility antigens. I. Serological and genetic characterization of GPLA antigens. Transplantation (1976) 0.83

The validity of the eosin technique as an index of viability. Exp Cell Res (1970) 0.83

Cell-mediated and humoral immune response in swine after vaccination and natural infection with Mycoplasma hyopneumoniae. Am J Vet Res (1981) 0.83

Distribution of a contact sensitizer, 1-fluoro-2,4-dinitro-benzene, in the the tissues of the guinea-pig. Immunology (1972) 0.83

T cell reactivity to penicillin: phenotypic analysis of in vitro activated cell subsets. J Allergy Clin Immunol (1986) 0.83